Angle (AGL)

Sector:

Support

Index:

FTSE AIM All-Share

14.00p
   
  • Change Today:
      0.25p
  • 52 Week High: 31.35
  • 52 Week Low: 9.24
  • Currency: UK Pounds
  • Shares Issued: 319.08m
  • Volume: 514,579
  • Market Cap: £44.67m
  • RiskGrade: 312

Latest ShareCast News

Angle unveils plans to raise more than £10m

By Abigail Townsend

Date: Wednesday 05 Jun 2024

(Sharecast News) - Liquid biopsy specialist Angle is to raise more than £10m to support future growth, the UK company announced on Wednesday.

Angle reports promising results from Parsortix study

By Benjamin Chiou

Date: Thursday 16 May 2024

(Sharecast News) - Angle, the AIM-listed liquid biopsy company which specialises in circulating tumour cell (CTC) solutions, has announced the results of a clinical study which show that its Parsortix system could be used to predict progression-free survival in patients with ovarian cancer.

Angle strikes supplier deal with AstraZeneca

By Iain Gilbert

Date: Friday 03 May 2024

(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Angle Market Data

Currency UK Pounds
Share Price 14.00p
Change Today 0.25p
% Change 1.82 %
52 Week High 31.35
52 Week Low 9.24
Volume 514,579
Shares Issued 319.08m
Market Cap £44.67m
RiskGrade 312

Angle Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.85% below the market average48.85% below the market average48.85% below the market average48.85% below the market average48.85% below the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
Price Trend
30.08% below the market average30.08% below the market average30.08% below the market average30.08% below the market average30.08% below the market average
41.41% below the sector average41.41% below the sector average41.41% below the sector average41.41% below the sector average41.41% below the sector average
Income Not Available
Growth
52.21% above the market average52.21% above the market average52.21% above the market average52.21% above the market average52.21% above the market average
55.10% above the sector average55.10% above the sector average55.10% above the sector average55.10% above the sector average55.10% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Angle Dividends

No dividends found

Trades for 18-Jun-2024

Time Volume / Share Price
16:22 4,151 @ 14.17p
16:13 20,000 @ 14.17p
15:39 9,788 @ 14.18p
15:30 10,000 @ 14.20p
15:29 10,000 @ 14.20p

Angle Key Personnel

CEO Andrew D Newland
Finance Director Ian F Griffiths
Chair Jan Groen

Top of Page